Figure 9.
Mean dSPM values for all 10 right hemisphere ROIs, analyzed separately for congruent and incongruent trials. (A) One-Way ANOVAs testing for differences across modalities on congruent trials were significant in IPS and LOT. (B) Effects for incongruent trials were significant in IFG, IPS, LOT, PT, and pSTS. *p < 0.05; **p < 0.01; ***p < 0.001.